New preprint from 23andMe Research 23andMe reports 4-5x success with genetic evidence for drug trial success.

Webinar: 90% of therapeutic programs in clinical trials fail. Join us Tues Aug 13 at 12pm ET to hear from Xin Wang, Ph.D. from 23andMe as she shares recent work on how the scale of genetic data and improved methods impact clinical success. Register here: bit.ly/3zWGI9y

In a preprint from the 23andMe Research team, we used Mendelian randomization to explore the genetically-predicted causal effects of Lp(a) on a range (n=489) of human traits and diseases. medrxiv.org/content/10.110…

Excited to share our latest paper, where we describe ITSN1 as a novel risk gene for Parkinson's disease! We found that rare loss-of-function variants are associated with a 10-fold increased odds of PD. As far as we know, this is the largest effect size reported for sporadic PD

Come join the webinar and hear about our latest update on how programs supported by genetic evidence from 23andMe improves clinical success!

📌Publication alert: In a preprint from the 23andMe Research team, we conducted one of the largest GWAS study of Long COVID and identified genetic links of chronic conditions with Long COVID. medrxiv.org/content/10.110…

The genetic architecture of gene expression in individuals of African and European ancestry medrxiv.org/cgi/content/sh… #medRxiv